grant
saveVAXIION THERAPEUTICS, INC. — Preclinical development of VAX024 - a novel targeted combination STING agonis...
September 16, 2025updated 2mo ago
community read0 votes
CA grant. $306,265. PI: Matthew Giacalone
view source ↗CA grant. $306,265. PI: Matthew Giacalone
view source ↗